Header

UZH-Logo

Maintenance Infos

A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential


Abstract

Zika virus (ZIKV), a mosquito-borne flavivirus, causes devastating congenital birth defects. We isolated a human monoclonal antibody (mAb), ZKA190, that potently cross-neutralizes multi-lineage ZIKV strains. ZKA190 is highly effective in vivo in preventing morbidity and mortality of ZIKV-infected mice. NMR and cryo-electron microscopy show its binding to an exposed epitope on DIII of the E protein. ZKA190 Fab binds all 180 E protein copies, altering the virus quaternary arrangement and surface curvature. However, ZIKV escape mutants emerged in vitro and in vivo in the presence of ZKA190, as well as of other neutralizing mAbs. To counter this problem, we developed a bispecific antibody (FIT-1) comprising ZKA190 and a second mAb specific for DII of E protein. In addition to retaining high in vitro and in vivo potencies, FIT-1 robustly prevented viral escape, warranting its development as a ZIKV immunotherapy.

Abstract

Zika virus (ZIKV), a mosquito-borne flavivirus, causes devastating congenital birth defects. We isolated a human monoclonal antibody (mAb), ZKA190, that potently cross-neutralizes multi-lineage ZIKV strains. ZKA190 is highly effective in vivo in preventing morbidity and mortality of ZIKV-infected mice. NMR and cryo-electron microscopy show its binding to an exposed epitope on DIII of the E protein. ZKA190 Fab binds all 180 E protein copies, altering the virus quaternary arrangement and surface curvature. However, ZIKV escape mutants emerged in vitro and in vivo in the presence of ZKA190, as well as of other neutralizing mAbs. To counter this problem, we developed a bispecific antibody (FIT-1) comprising ZKA190 and a second mAb specific for DII of E protein. In addition to retaining high in vitro and in vivo potencies, FIT-1 robustly prevented viral escape, warranting its development as a ZIKV immunotherapy.

Statistics

Citations

Dimensions.ai Metrics
18 citations in Web of Science®
14 citations in Scopus®
15 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 12 Oct 2017
1 download since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:07 Faculty of Science > Department of Chemistry
Dewey Decimal Classification:540 Chemistry
Uncontrolled Keywords:Zikka, Antibody
Language:English
Date:2017
Deposited On:12 Oct 2017 08:58
Last Modified:21 Sep 2018 00:01
Publisher:Cell Press (Elsevier)
ISSN:0092-8674
Funders:Singapore Ministry of Education Tier 3 grant (MOE2012-T3-1-008),, National Research Foundation Investigator- ship award (NRF-NRFI2016-01), ational Research Foundation Competitive Research Project grant (NRF2016NRF-CRP001-063), 5U19AI109761 from the US National Institutes of Health, SNF grant 310030_166445, 157699, KFS-3728-08-2015
OA Status:Green
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1016/j.cell.2017.09.002
Project Information:
  • : Funder
  • : Grant ID
  • : Project TitleSingapore Ministry of Education Tier 3 grant (MOE2012-T3-1-008),
  • : Funder
  • : Grant ID
  • : Project TitleNational Research Foundation Investigator- ship award (NRF-NRFI2016-01)
  • : Funder
  • : Grant ID
  • : Project Titleational Research Foundation Competitive Research Project grant (NRF2016NRF-CRP001-063)
  • : Funder
  • : Grant ID
  • : Project Title5U19AI109761 from the US National Institutes of Health
  • : FunderSNSF
  • : Grant ID
  • : Project TitleSNF grant 310030_166445, 157699, KFS-3728-08-2015

Download

Download PDF  'A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential'.
Preview
Content: Accepted Version
Language: English
Filetype: PDF
Size: 866kB
View at publisher
Licence: Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)